Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Scancell Holdings (SCLP)

Price 15.00p on 22-10-2024 at 16:30:01
Change 1.25p 9.26%
Buy 15.50p
Sell 14.50p
Buy / Sell SCLP Shares
Last Trade: Sell 100,000.00 at 14.75p
Day's Volume: 2,640,704
Last Close: 14.75p
Open: 13.50p
ISIN: GB00B63D3314
Day's Range 14.00p - 14.75p
52wk Range: 8.70p - 19.50p
Market Capitalisation: £137m
VWAP: 14.40596p
Shares in Issue: 930m

Recent Trades History Scancell Holdings (SCLP)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 100,000 14.75p Uncrossing Trade
16:35:12 - 22-Oct-24
Sell* 19,821 14.835p Ordinary
16:25:44 - 22-Oct-24
Sell* 2,267 14.95p Ordinary
16:21:43 - 22-Oct-24
Unknown* 15,000 15.00p Ordinary
16:12:47 - 22-Oct-24
Buy* 131 15.25p Ordinary
15:49:14 - 22-Oct-24
Sell* 6,724 14.56p Ordinary
15:43:21 - 22-Oct-24
Sell* 3,000 14.835p Ordinary
15:35:16 - 22-Oct-24
Sell* 18,100 14.99p Ordinary
15:31:43 - 22-Oct-24
Sell* 18,100 14.99p Ordinary
15:30:19 - 22-Oct-24
Unknown* 18,100 15.00p Ordinary
15:28:42 - 22-Oct-24

Share Price History for Scancell Holdings

Time period:
to
Date Open High Low Close Volume

Share News for Scancell Holdings

UK shareholder meetings calendar - next 7 days

18th Oct 2024 15:40

Read More

EARNINGS: HSS Hire swings to loss, while Niox profit increases

24th Sep 2024 21:29

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

TRADING UPDATES: Creo extends contract; Belluscura raises funds

2nd Jul 2024 20:03

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

Shares in Scancell climb as strikes exclusive drug evaluation deal

12th Jun 2024 13:13

(Alliance News) - Scancell Holdings PLC on Wednesday announced a major international biotechnology company will exclusively evaluate a Scancell investigational anti-glycan monoclonal antibody for development of novel therapeutic products. Read More

Scancell doses first patient in melanoma-focused trials

26th Mar 2024 14:00

(Alliance News) - Scancell Holdings PLC announced on Tuesday that the first patient of a new trial cohort has been dosed with its iSCIB1+ therapeutic. Read More

FTSE 100 Latest
Value8,306.54
Change-11.70

Login to your account

Forgot Password?

Not Registered